The Reglan drug, also known by the generic name “metoclopramide”, was first approved by the FDA in 1980. It is currently available in several different forms in both the branded “Reglan” and generic “metoclopramide” products. Reglan medication is commonly misspelled as: Reglun, Regland and Reglund.
Reglan is prescribed for both adults and children depending on the treatment. The drug is used for several different therapies including:
• Acid reflux
• GERD (gastroesphageal reflux disease)
• Diabetic gatroparesis
• Nausea from migraines and following surgery
• Breastfeeding mothers – increase milk production
According to estimates over two million people living in the United States use products containing the Reglan medication (metoclopramide). According to the FDA:
“Recently published analyses suggest that metoclopramide is the most common cause of drug-induced movement disorders. Another analysis of study data by the FDA showed that about 20 percent of patients in that study who used metoclopramide took it for longer than three months. The FDA has also become aware of continued spontaneous reports of tardive dyskinesia in patients who used metoclopramide, the majority of whom had taken the drug for more than three months.”
Reglan drug side effects include:
• Tardive dyskinesia
• Parkinsons symptoms
• Neuroleptic malignant syndrome
• Akathasia
• Cervical dystonia (torticollis)
Tardive dyskinesia (TD) is a drug-induced movement disorder caused by the long-term use of neuroleptic drugs. Tardive means “delayed” and dyskinesia means “abnormal movement.” This serious neurological syndrome is often irreversible and may become permanent. Since the 1950’s a family of drugs referred to as dopamine receptor blocking drugs (DRB) have been prescribed for certain mental health conditions and are now also commonly prescribed for the treatment of GERD and nausea. Metoclopramide - Reglan is a dopamine receptor blocking drug.
Reglan acts in the upper end of the digestive system and works by speeding up the movement of the stomach muscles, thus increasing the rate at which the stomach empties into the intestines. It is used as a short-term treatment of gastroesophageal reflux disease in patients who have not responded to other therapies, and to treat diabetic gastroparesis (slowed emptying of the stomach’s contents into the intestines). It is recommended that treatment not exceed twelve weeks, however it is estimated that around thirty percent of patients who are prescribed products containing metoclopramide take the medication for a period of time that exceeds that recommended in the product label insert.
The Reglan drug, also known by the generic name “metoclopramide”, was first approved by the FDA in 1980. It is currently available in several different forms in both the branded “Reglan” and generic “metoclopramide” products. Reglan medication is commonly misspelled as: Reglun, Regland and Reglund.
dallas criminal lawyer www.mcconathylaw.com - our office has successfully defended 42 out of 47 dwi cases set for trial by either not guilty or dismissal since january of 2003.